People · Operator
Named in public records as an officer, director or promoter · active 2018–2026 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| ONL Therapeutics, Inc. | — | Biotechnology | Series C | $111.5M | $496.0M | 2018 |
| CubeWorks, Inc. | — | Other Technology | Series A | $19.5M | $11.5M | 2024 |
Felicia David-Visser at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Felicia David-Visser on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michal Silverberg | 1 | 7 |
| Aaron Fletcher | 1 | 5 |
| Marian Nakada | 1 | 4 |
| Stella Robertson | 1 | 4 |
| Rafael Castilla | 1 | 3 |
| Saman Farid | 1 | 2 |
| Dennis Sylvester | 1 | 2 |
| Tammi Smorynski | 1 | 2 |
| Thomas M. Leonard | 1 | 2 |
| Mark K Hooper | 1 | 1 |
| Michael Hurton | 1 | 1 |
| Gyouho Kim | 1 | 1 |
| Stephen K. DiRubio | 1 | 1 |
| ZhiYoong Foo | 1 | 1 |
| David Blaauw | 1 | 1 |
| Mike Witteman | 1 | 1 |
| Yoonmyung Lee | 1 | 1 |
| David Wenzloff | 1 | 1 |
| Liu Wei | 1 | 1 |
| Prabal Dutta | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.